1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow Speech Disorders: new trials by email Literature Review of Speech Disorders trials Research Report on Speech Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study of Neflamapimod in Patients With Primary Progressive Aphasia Neflamapimod, Placebo - Nonfluent Variant Primary Progressive Aphasia (nfvPPA) | Phase 2 | Active not recruiting | EIP Pharma Inc | 20 | 2025-10-02 | 2026-07-06 |
Aphasia (1) · Aphasia, Primary Progressive (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Frontotemporal Dementia (1) · Language Disorders (1) · Mental Disorders (1) · Nervous System Diseases (1) · Neurocognitive Disorders (1) · Neurodegenerative Diseases (1) · Speech (1)
Behavior (1) · Communication (1) · Communication Disorders (1) · Dementia (1) · Frontotemporal Lobar Degeneration (1) · Metabolic Diseases (1) · Neurobehavioral Manifestations (1) · Neurologic Manifestations (1) · Nutritional and Metabolic Diseases (1) · Pathological Conditions, Signs and Symptoms (1) · Proteostasis Deficiencies (1) · Signs and Symptoms (1) · TDP-43 Proteinopathies (1) · Verbal Behavior (1)
EIP Pharma Inc (1)
United Kingdom (1) · United States (1)